S

SciClone Pharmaceuticals (Holdings) Ltd
HKEX:6600

Watchlist Manager
SciClone Pharmaceuticals (Holdings) Ltd
HKEX:6600
Watchlist
Price: 18.72 HKD Market Closed
Market Cap: 11.8B HKD
Have any thoughts about
SciClone Pharmaceuticals (Holdings) Ltd?
Write Note

Intrinsic Value

The intrinsic value of one SciClone Pharmaceuticals (Holdings) Ltd stock under the Base Case scenario is 30.05 HKD. Compared to the current market price of 18.72 HKD, SciClone Pharmaceuticals (Holdings) Ltd is Undervalued by 38%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

Intrinsic Value
30.05 HKD
Undervaluation 38%
Intrinsic Value
Price
S
Worst Case
Base Case
Best Case

Valuation History
SciClone Pharmaceuticals (Holdings) Ltd

Compare SciClone Pharmaceuticals (Holdings) Ltd to

Fundamental Analysis

SciClone Pharmaceuticals (Holdings) Ltd
HKEX:6600
CN
Pharmaceuticals
Market Cap
11.3B HKD
IPO
Mar 3, 2021
CN
Pharmaceuticals
Market Cap
11.3B HKD
IPO
Mar 3, 2021
Price
HK$
ÂĄ
Company Overview
Loading...
Business Segments
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about SciClone Pharmaceuticals (Holdings) Ltd?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about SciClone Pharmaceuticals (Holdings) Ltd

Provide an overview of the primary business activities
of SciClone Pharmaceuticals (Holdings) Ltd.

What unique competitive advantages
does SciClone Pharmaceuticals (Holdings) Ltd hold over its rivals?

What risks and challenges
does SciClone Pharmaceuticals (Holdings) Ltd face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for SciClone Pharmaceuticals (Holdings) Ltd.

Provide P/S
for SciClone Pharmaceuticals (Holdings) Ltd.

Provide P/E
for SciClone Pharmaceuticals (Holdings) Ltd.

Provide P/OCF
for SciClone Pharmaceuticals (Holdings) Ltd.

Provide P/FCFE
for SciClone Pharmaceuticals (Holdings) Ltd.

Provide P/B
for SciClone Pharmaceuticals (Holdings) Ltd.

Provide EV/S
for SciClone Pharmaceuticals (Holdings) Ltd.

Provide EV/GP
for SciClone Pharmaceuticals (Holdings) Ltd.

Provide EV/EBITDA
for SciClone Pharmaceuticals (Holdings) Ltd.

Provide EV/EBIT
for SciClone Pharmaceuticals (Holdings) Ltd.

Provide EV/OCF
for SciClone Pharmaceuticals (Holdings) Ltd.

Provide EV/FCFF
for SciClone Pharmaceuticals (Holdings) Ltd.

Provide EV/IC
for SciClone Pharmaceuticals (Holdings) Ltd.

Show me price targets
for SciClone Pharmaceuticals (Holdings) Ltd made by professional analysts.

What are the Revenue projections
for SciClone Pharmaceuticals (Holdings) Ltd?

How accurate were the past Revenue estimates
for SciClone Pharmaceuticals (Holdings) Ltd?

What are the Net Income projections
for SciClone Pharmaceuticals (Holdings) Ltd?

How accurate were the past Net Income estimates
for SciClone Pharmaceuticals (Holdings) Ltd?

What are the EPS projections
for SciClone Pharmaceuticals (Holdings) Ltd?

How accurate were the past EPS estimates
for SciClone Pharmaceuticals (Holdings) Ltd?

What are the EBIT projections
for SciClone Pharmaceuticals (Holdings) Ltd?

How accurate were the past EBIT estimates
for SciClone Pharmaceuticals (Holdings) Ltd?

Compare the revenue forecasts
for SciClone Pharmaceuticals (Holdings) Ltd with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of SciClone Pharmaceuticals (Holdings) Ltd and its key competitors using the latest financial data.

Compare historical revenue growth rates
of SciClone Pharmaceuticals (Holdings) Ltd against its competitors.

Analyze the profit margins
(gross, operating, and net) of SciClone Pharmaceuticals (Holdings) Ltd compared to its peers.

Compare the P/E ratios
of SciClone Pharmaceuticals (Holdings) Ltd against its peers.

Discuss the investment returns and shareholder value creation
comparing SciClone Pharmaceuticals (Holdings) Ltd with its peers.

Analyze the financial leverage
of SciClone Pharmaceuticals (Holdings) Ltd compared to its main competitors.

Show all profitability ratios
for SciClone Pharmaceuticals (Holdings) Ltd.

Provide ROE
for SciClone Pharmaceuticals (Holdings) Ltd.

Provide ROA
for SciClone Pharmaceuticals (Holdings) Ltd.

Provide ROIC
for SciClone Pharmaceuticals (Holdings) Ltd.

Provide ROCE
for SciClone Pharmaceuticals (Holdings) Ltd.

Provide Gross Margin
for SciClone Pharmaceuticals (Holdings) Ltd.

Provide Operating Margin
for SciClone Pharmaceuticals (Holdings) Ltd.

Provide Net Margin
for SciClone Pharmaceuticals (Holdings) Ltd.

Provide FCF Margin
for SciClone Pharmaceuticals (Holdings) Ltd.

Show all solvency ratios
for SciClone Pharmaceuticals (Holdings) Ltd.

Provide D/E Ratio
for SciClone Pharmaceuticals (Holdings) Ltd.

Provide D/A Ratio
for SciClone Pharmaceuticals (Holdings) Ltd.

Provide Interest Coverage Ratio
for SciClone Pharmaceuticals (Holdings) Ltd.

Provide Altman Z-Score Ratio
for SciClone Pharmaceuticals (Holdings) Ltd.

Provide Quick Ratio
for SciClone Pharmaceuticals (Holdings) Ltd.

Provide Current Ratio
for SciClone Pharmaceuticals (Holdings) Ltd.

Provide Cash Ratio
for SciClone Pharmaceuticals (Holdings) Ltd.

What is the historical Revenue growth
over the last 5 years for SciClone Pharmaceuticals (Holdings) Ltd?

What is the historical Net Income growth
over the last 5 years for SciClone Pharmaceuticals (Holdings) Ltd?

What is the current Free Cash Flow
of SciClone Pharmaceuticals (Holdings) Ltd?

Discuss the annual earnings per share (EPS)
trend over the past five years for SciClone Pharmaceuticals (Holdings) Ltd.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Revenue & Expenses Breakdown
SciClone Pharmaceuticals (Holdings) Ltd

Balance Sheet Decomposition
SciClone Pharmaceuticals (Holdings) Ltd

Current Assets 3.4B
Cash & Short-Term Investments 2B
Receivables 868m
Other Current Assets 582.5m
Non-Current Assets 553.1m
Long-Term Investments 110.6m
PP&E 39.4m
Intangibles 396m
Other Non-Current Assets 7m
Current Liabilities 698.2m
Accounts Payable 859.7m
Accrued Liabilities 153.1m
Other Current Liabilities -314.6m
Non-Current Liabilities 36.9m
Long-Term Debt 19.8m
Other Non-Current Liabilities 17.2m
Efficiency

Free Cash Flow Analysis
SciClone Pharmaceuticals (Holdings) Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
SciClone Pharmaceuticals (Holdings) Ltd

Revenue
3.2B CNY
Cost of Revenue
-799.4m CNY
Gross Profit
2.4B CNY
Operating Expenses
-1.1B CNY
Operating Income
1.3B CNY
Other Expenses
-135.8m CNY
Net Income
1.1B CNY
Fundamental Scores

Profitability Score
Profitability Due Diligence

SciClone Pharmaceuticals (Holdings) Ltd's profitability score is 82/100. The higher the profitability score, the more profitable the company is.

Exceptional 3Y Average ROIC
Exceptional 3Y Average ROE
Exceptional ROIC
Exceptional ROE
82/100
Profitability
Score

SciClone Pharmaceuticals (Holdings) Ltd's profitability score is 82/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

SciClone Pharmaceuticals (Holdings) Ltd's solvency score is 99/100. The higher the solvency score, the more solvent the company is.

High Interest Coverage
High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
99/100
Solvency
Score

SciClone Pharmaceuticals (Holdings) Ltd's solvency score is 99/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
SciClone Pharmaceuticals (Holdings) Ltd

There are no price targets for SciClone Pharmaceuticals (Holdings) Ltd.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for SciClone Pharmaceuticals (Holdings) Ltd is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y
What is the Intrinsic Value of one SciClone Pharmaceuticals (Holdings) Ltd stock?

The intrinsic value of one SciClone Pharmaceuticals (Holdings) Ltd stock under the Base Case scenario is 30.05 HKD.

Is SciClone Pharmaceuticals (Holdings) Ltd stock undervalued or overvalued?

Compared to the current market price of 18.72 HKD, SciClone Pharmaceuticals (Holdings) Ltd is Undervalued by 38%.

Back to Top